Takeda Pharmaceutical Company Continues Global R&D Reboot, Enters JV With PRA Health
April 07, 2017 at 20:48 PM EDT
PRA Health Sciences (NASDAQ:PRAH) has entered into a joint venture with Takeda Pharmaceutical Company Limited to further globalize Takeda’s development business in Japan.
